ES557213A0 - Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos - Google Patents

Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos

Info

Publication number
ES557213A0
ES557213A0 ES557213A ES557213A ES557213A0 ES 557213 A0 ES557213 A0 ES 557213A0 ES 557213 A ES557213 A ES 557213A ES 557213 A ES557213 A ES 557213A ES 557213 A0 ES557213 A0 ES 557213A0
Authority
ES
Spain
Prior art keywords
sulphonylamine
procedure
preparing new
ethyl compounds
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557213A
Other languages
English (en)
Other versions
ES8705857A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19853508692 external-priority patent/DE3508692A1/de
Priority claimed from DE19853541854 external-priority patent/DE3541854A1/de
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES8705857A1 publication Critical patent/ES8705857A1/es
Publication of ES557213A0 publication Critical patent/ES557213A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • C07D213/71Sulfur atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES557213A 1985-03-12 1986-11-20 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos Expired ES8705857A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853508692 DE3508692A1 (de) 1985-03-12 1985-03-12 3-(4-(2-benzolsulfonylamino-aethyl)-benzoyl)propionsaeure, diese verbindung enthaltende arzneimittel und verfahren zu ihrer herstellung
DE19853541854 DE3541854A1 (de) 1985-11-27 1985-11-27 Neue sulfonylaminoaethylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES8705857A1 ES8705857A1 (es) 1987-05-16
ES557213A0 true ES557213A0 (es) 1987-05-16

Family

ID=25830225

Family Applications (5)

Application Number Title Priority Date Filing Date
ES552870A Expired ES8800664A1 (es) 1985-03-12 1986-03-11 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES557210A Expired ES8705378A1 (es) 1985-03-12 1986-11-20 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES557213A Expired ES8705857A1 (es) 1985-03-12 1986-11-20 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES557212A Expired ES8705856A1 (es) 1985-03-12 1986-11-20 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES557211A Expired ES8705855A1 (es) 1985-03-12 1986-11-20 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES552870A Expired ES8800664A1 (es) 1985-03-12 1986-03-11 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES557210A Expired ES8705378A1 (es) 1985-03-12 1986-11-20 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES557212A Expired ES8705856A1 (es) 1985-03-12 1986-11-20 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES557211A Expired ES8705855A1 (es) 1985-03-12 1986-11-20 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos

Country Status (11)

Country Link
EP (1) EP0194548A3 (es)
AU (1) AU5461286A (es)
DK (1) DK110886A (es)
ES (5) ES8800664A1 (es)
FI (1) FI860971A (es)
GR (1) GR860654B (es)
HU (1) HU195770B (es)
IL (1) IL78079A0 (es)
NO (1) NO860918L (es)
PH (1) PH22480A (es)
PT (1) PT82169B (es)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3535167A1 (de) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel
DE3623944A1 (de) * 1986-07-16 1988-02-11 Thomae Gmbh Dr K Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL83230A (en) * 1986-08-06 1992-06-21 Tanabe Seiyaku Co Phenoxyacetic acid derivatives,their preparation and pharmaceutical compositions containing them
TR23997A (tr) * 1986-10-27 1991-01-15 Chem Fab Stockmausen Gmbh N,n disuebstituee beta-aminopropionik asitleri imale mahsus usul ve bunlarin temizleme maddeleri icindeki tensidler,islatma maddeleri suebyelestiri- ci maddeler olarak ve kuerklerin ve derilerin hidro
GB8708233D0 (en) * 1987-04-07 1987-05-13 Smith Kline French Lab Pharmaceutically active compounds
GB8717374D0 (en) * 1987-07-22 1987-08-26 Smith Kline French Lab Pharmaceutically active compounds
US4752613A (en) * 1987-08-03 1988-06-21 E. R. Squibb & Sons, Inc. Sulphonamidothienylcarboxylic acid compounds
US5962490A (en) * 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5591761A (en) * 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5571821A (en) * 1993-05-20 1996-11-05 Texas Biotechnology Corporation Sulfonamides and derivatives thereof that modulate the activity of endothelin
US5514691A (en) * 1993-05-20 1996-05-07 Immunopharmaceutics, Inc. N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5594021A (en) * 1993-05-20 1997-01-14 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
AT393962B (de) * 1987-10-22 1992-01-10 Thomae Gmbh Dr K Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung
DE3819052A1 (de) * 1988-06-04 1989-12-07 Basf Ag Neue sulfonamid-derivate, ihre herstellung und verwendung
US5280043A (en) * 1988-10-10 1994-01-18 Smith Kline & French Laboratories Ltd. Sulphonamido containing phenylalkanoic acids as thromboxane A2 antagonists
US4975452A (en) * 1989-06-02 1990-12-04 E. R. Squibb & Sons, Inc. Geminally substituted thiaheterocyclic carboxylic acids and derivatives thereof
US5106991A (en) * 1989-06-02 1992-04-21 E. R. Squibb & Sons, Inc. Geminally substituted thiaheterocyclic carboxylic acids and derivatives thereof
DE4035961A1 (de) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5280034A (en) * 1991-08-23 1994-01-18 E. R. Squibb & Sons, Inc. Bis-heterocyclic prostaglandin analogs
US5378715A (en) * 1992-02-24 1995-01-03 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
DE4213919A1 (de) * 1992-04-28 1993-11-04 Thomae Gmbh Dr K Cyclische iminoderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5514696A (en) * 1992-05-06 1996-05-07 Bristol-Myers Squibb Co. Phenyl sulfonamide endothelin antagonists
US5739132A (en) * 1992-07-02 1998-04-14 Tanabe Seiyaku Co., Ltd. Pyridazinone derivatives and processes for preparing the same
CA2099743A1 (en) * 1992-07-02 1994-01-03 Akihiko Ishida Pyridazinone derivatives and processes for preparing the same
US5420123A (en) * 1992-12-21 1995-05-30 Bristol-Myers Squibb Company Dibenzodiazepine endothelin antagonists
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US5965732A (en) * 1993-08-30 1999-10-12 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
CA2138812A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivative and processes for preparing the same
CA2139088A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivatives, processes for preparing the same and synthetic intermediate of the same
US5612359A (en) * 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
US5780473A (en) * 1995-02-06 1998-07-14 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
US5760038A (en) * 1995-02-06 1998-06-02 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
IL118631A (en) * 1995-06-27 2002-05-23 Tanabe Seiyaku Co History of pyridazinone and processes for their preparation
US5846990A (en) * 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
JPH09124620A (ja) * 1995-10-11 1997-05-13 Bristol Myers Squibb Co 置換ビフェニルスルホンアミドエンドセリン拮抗剤
US5856507A (en) * 1997-01-21 1999-01-05 Bristol-Myers Squibb Co. Methods for the preparation of biphenyl isoxazole sulfonamides
SG87053A1 (en) 1996-02-20 2002-03-19 Bristol Myers Squibb Co High melt polymorth of the compound n-(3,4-dimethyl-5-isoxazolyl)-4'- (2-oxazolyl) [1,1'-biphenyl]-2-sulfonamide
US5958905A (en) 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
US5939446A (en) * 1996-04-09 1999-08-17 Bristol-Myers Squibb Co. Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
US5804585A (en) 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
TW536540B (en) * 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
SK143399A3 (en) 1997-04-28 2000-05-16 Texas Biotechnology Corp Sulfonamides for treatment of endothelin-mediated disorders
US5783705A (en) 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
MXPA01009362A (es) 1999-03-19 2002-06-04 Squibb Bristol Myers Co Metodos para la preparacion de bifenil isoxazol sulfonamidas.
US6639082B2 (en) 2000-10-17 2003-10-28 Bristol-Myers Squibb Company Methods for the preparation of biphenyl isoxazole sulfonamides
MY148634A (en) 2006-07-25 2013-05-15 Cephalon Inc Pyridazinone derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3535167A1 (de) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel

Also Published As

Publication number Publication date
ES8705857A1 (es) 1987-05-16
ES557212A0 (es) 1987-05-16
ES557210A0 (es) 1987-05-01
HU195770B (en) 1988-07-28
ES557211A0 (es) 1987-05-16
EP0194548A2 (de) 1986-09-17
HUT42062A (en) 1987-06-29
PH22480A (en) 1988-09-12
ES8705855A1 (es) 1987-05-16
PT82169B (de) 1988-01-04
NO860918L (no) 1986-09-15
DK110886D0 (da) 1986-03-11
DK110886A (da) 1986-09-13
ES8705856A1 (es) 1987-05-16
FI860971A (fi) 1986-09-13
FI860971A0 (fi) 1986-03-10
AU5461286A (en) 1986-10-16
PT82169A (de) 1986-04-01
ES552870A0 (es) 1987-11-16
GR860654B (en) 1986-07-11
IL78079A0 (en) 1986-07-31
ES8705378A1 (es) 1987-05-01
ES8800664A1 (es) 1987-11-16
EP0194548A3 (de) 1988-08-17

Similar Documents

Publication Publication Date Title
ES552870A0 (es) Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES557241A0 (es) Procedimiento para preparar nuevos 2-aril-imidazoles
ES544204A0 (es) Procedimiento para preparar dialcoxipiridinas
ES542976A0 (es) Procedimiento para preparar pirrolo-bencimidazoles
ES548921A0 (es) Procedimiento para preparar nuevos derivados de aminotetra- lina
ES550113A0 (es) Procedimiento para preparar compuestos carbostirilicos
ES546314A0 (es) Procedimiento para preparar nuevos compuestos de 3-piridilo
ES551807A0 (es) Procedimiento para preparar piridinil acilhidrazonas
ES557522A0 (es) Procedimiento para preparar derivados de cinolina
ES552089A0 (es) Un procedimiento para preparar compuestos de oxazolidina-fenol-alcohol
ES557692A0 (es) Procedimiento para preparar derivados de imidazolilalquilguanidina
ES554112A0 (es) Procedimiento para preparar compuestos de ciclohexil y cicloexenil-imidazol
ES552955A0 (es) Procedimiento para preparar derivados de bencimidazol substituidos
ES550961A0 (es) Procedimiento para preparar derivados azolilalquilicos
ES553814A0 (es) Un procedimiento para preparar nuevos derivados de aminocetona
ES544622A0 (es) Procedimiento para preparar l-fenilalamina
ES544074A0 (es) Procedimiento para preparar naftoxacinas
ES557630A0 (es) Procedimiento para preparar dihidropiridinas
ES557574A0 (es) Un procedimiento para preparar nuevos compuestos de 2-oxa-o -aza-pregnano
ES555036A0 (es) Procedimiento para preparar derivados de oxadiazolilimidazobenzodiazepina
ES554133A0 (es) Procedimiento para preparar 2-(n-alquinil-n-fenilamino)-imidazolinas
ES541140A0 (es) Procedimiento para preparar derivados carboxialquildipepti- dicos
ES554068A0 (es) Procedimiento para preparar compuestos diarilicos
ES543014A0 (es) Procedimiento para preparar nuevos derivados de quinoleina
ES551226A0 (es) Procedimiento para preparar 5-fluorprostaciclinas